Results 151 to 160 of about 9,731 (238)

Serum SERPINB3/4 in Moderate-to-Severe Prurigo Nodularis: A Potential Biomarker for Disease Severity and Eosinophil-Related Parameters. [PDF]

Immun Inflamm Dis
Wu J, Zhang K, Liao Y, Yang C, Ge J, Wu C, Yu B, Zhong W, Shao Y, Dou X.   +9 more
europepmc   +1 more source

The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies. [PDF]

Int J Mol Sci
Pala V, Rosset F, Mastorino L, Sciamarrelli N, Boskovic S, Borriello S, Bongiovanni E, Crespi O, Ribero S, Quaglino P.   +9 more
europepmc   +1 more source

Upadacitinib for prurigo nodularis

JAAD Case Reports
Clara Muntaner-Virgili, MD, Carlos Moreno-Vilchez, MD, Clara Torrecilla-Vall-Llossera, MD, Ignasi Figueras-Nart, MD   +3 more
doaj   +1 more source

Dupilumab in Elderly Patients with Atopic Dermatitis-A Systematic Review and Meta-Analysis. [PDF]

Biomedicines
Hałubiec P, Gołąbek N, Wojas-Pelc A, Szepietowski JC, Jaworek AK.   +4 more
europepmc   +1 more source

Vixarelimab in Patients With Prurigo Nodularis: A Randomized Clinical Trial.

JAMA Dermatol
Ständer S, Yosipovitch G, Sofen H, Abramzon D, Galanter J, Wang S, Paolini JF.   +6 more
europepmc   +1 more source

Prurigo Nodularis in a Patient With Primary B-Cell Immunodeficiency Successfully Treated With Low-Dose Methotrexate: A Case Report. [PDF]

Clin Case Rep
El Hajj H, Jeha D, Abi Younis J, Noun P, Habre M.   +4 more
europepmc   +1 more source

Immune checkpoint inhibitor-associated acquired reactive perforating collagenosis treated with dupilumab. [PDF]

JAAD Case Rep
Gold M, Mueller K, Bogner P, Kuraitis D.
europepmc   +1 more source

Treatment Patterns, Healthcare Utilization, and Related Costs for Prurigo Nodularis in Sweden. [PDF]

Acta Derm Venereol
Von Kobyletzki L, Metsini A, Regnell SE, Carlberg M, Svensson Å, Antelmi A.   +5 more
europepmc   +1 more source

Plasma cytokine profiling identifies early kidney injury and systemic inflammation in prurigo nodularis. [PDF]

JAAD Int
Akiska YM, Khoshniyati S, Fayyad D, Afzal S, Bhagchandani P, Gage D, Shahsavari S, Born LJ, Vats K, Patel SS, Kwatra SG.   +10 more
europepmc   +1 more source

Paradoxical morphea-like reaction after initiation of dupilumab for nodular prurigo. [PDF]

An Bras Dermatol
González Fernández J, Ara Martín M, García González S, Martínez Cisneros SP, García García M, de la Fuente Meira S.   +5 more
europepmc   +1 more source